Skip to main content

Day: August 6, 2020

Plug Power Announces 2020 Second Quarter Results

LATHAM, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a leading provider of hydrogen engines and fueling solutions enabling e-mobility, has announced today its 2020 second quarter results. The quarterly shareholder letter has been posted at http://www.ir.plugpower.com/Q220Plug.Join the call:Date: August 6, 2020Time: 10:00 am ETParticipant Dial-In: 877-405-1239 / 201-389-0851Direct webcast: https://event.webcasts.com/starthere.jsp?ei=1351078&tp_key=c7fe17e5faBoth the shareholder letter and webcast can be accessed at www.plugpower.com, on the company’s home and investor relations pages. A playback of the call will be available online for a period following the event.About Plug Power Inc.Plug Power is building the hydrogen economy as the leading provider of comprehensive hydrogen fuel cell (HFC) turnkey...

Continue reading

ADT Announces Notes Offering

BOCA RATON, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT) (the “Company” or “ADT”), a leading provider of security, automation, and smart home solutions serving consumer and business customers in the United States, announced that Prime Security Services Borrower, LLC (the “Issuer”) and Prime Finance Inc. (the “Co-Issuer” and, together with the Issuer, the “Issuers”), its indirect wholly owned subsidiaries, are proposing to issue and sell $750 million aggregate principal amount of first-priority senior secured notes due 2027 (the “Notes”) in an offering that will be exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”) (the “Offering”).Upon the satisfactory consummation of the Offering, The ADT Security Corporation (“ADTSC”), an indirect wholly owned subsidiary of...

Continue reading

IBI Group Plays Major Design Role on Broadway Subway Expansion as Part of Acciona-Ghella Preferred Proponent Joint Venture

TORONTO, Aug. 06, 2020 (GLOBE NEWSWIRE) — IBI Group (TSX:IBG) is part of the Acciona-Ghella Joint Venture (AGJV), the preferred proponent team for the Broadway Subway Project in Vancouver, British Columbia. IBI Group will serve as Project Architect, and Architect and Engineer of Record on four stations as part of the AGJV, as announced by the BC Government on July 17, 2020. The $2.83B design-build-finance project is an extension to the existing Millennium Line, consisting of 5.7km of advanced light rapid transit (SkyTrain) and six underground stations. Construction is scheduled to start in late 2020, with the line going into service in 2025. The project adds to IBI Group’s global expertise designing transit infrastructure, including on Toronto’s Eglinton Crosstown LRT and Hurontario LRT, the Edmonton Valley Line LRT, Ottawa Confederation...

Continue reading

Notice of Knight Therapeutics’ Second Quarter 2020 Results Conference Call

MONTREAL, Aug. 06, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2020 financial results on Thursday, August 13, 2020 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call.Date: Thursday, August 13, 2020

Continue reading

Avis de conférence téléphonique de Thérapeutique Knight sur ses résultats du deuxième trimestre 2020

MONTRÉAL, 06 août 2020 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou « la Société »), société pharmaceutique spécialisée panaméricaine (ex. EU) et chef de file, publiera ses résultats financiers du deuxième trimestre 2020, ce jeudi 13 juin 2020 avant l’ouverture du marché. À la suite de cette publication, Knight sera l’hôte d’une conférence téléphonique et d’une webémission. Knight invite cordialement toutes les parties intéressées à participer à cet appel.Date : Jeudi 13 août 2020

Continue reading

Kelly® Reports Second Quarter Earnings

Financial HighlightsQ2 revenue declined 28.7% or 27.7% in constant currencyQ2 operating earnings of $11.1 million, down 68.2%, or down 50.4% as adjustedQ2 earnings per share of $1.04, down 50.9%, or down 37.0% as adjustedTROY, Mich., Aug. 06, 2020 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA) (Nasdaq: KELYB), a leading specialty talent solutions provider, today announced results for the second quarter of 2020.Peter Quigley, president and chief executive officer, announced revenue for the second quarter of 2020 totaled $1.0 billion, a 28.7% decline, or 27.7% in constant currency, compared to the corresponding quarter of 2019.  Revenues declined as a result of lower demand during the quarter as customers reacted to the COVID-19 crisis.Earnings from operations for the second quarter of 2020 totaled $11.1 million, compared to the $34.8 million...

Continue reading

FTI Consulting Expands Global Aviation Offering

WASHINGTON, Aug. 06, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced continued investment in its Aviation offering with the launch of a dedicated global industry practice and the appointment of two Senior Managing Directors and four Managing Directors. This team will immediately enhance the firm’s depth of expertise for airlines, manufacturers, lenders, lessors, investors and other aviation-industry players, as they continue to respond to the changing environment, stabilize their businesses amid profound uncertainty and take a leading position to emerge from the downturn.Marc Bilbao and Neal Cohen join FTI Consulting as Senior Managing Directors within the Corporate Finance & Restructuring segment and Co-Leaders of the global Aviation offering. Scott Farnsworth, Joseph Kazanovski and Beau Roy have joined...

Continue reading

Intellia Therapeutics Announces Second Quarter 2020 Financial Results

Submitted first regulatory application to the U.K.’s MHRA to initiate a Phase 1 study of NTLA-2001 for the treatment of transthyretin amyloidosis; on track to dose first patient by year-endExpanded Regeneron collaboration, receiving $100 million through upfront cash and equity investment and agreeing to co-develop treatments for hemophilia A and B using CRISPR-mediated targeted transgene insertion technologyOn track to submit an IND or IND-equivalent in 2021 for each of two wholly owned programs: NTLA-5001 for the treatment of acute myeloid leukemia and NTLA-2002 for the treatment of hereditary angioedemaEnded quarter with strong cash position of $436.8 millionCAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics...

Continue reading

Alico, Inc. Announces Two New Appointments to the Board of Directors

FORT MYERS, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announces the appointment of two new members to the Company’s Board of Directors (the “Board”).Joining our Board is Ms. Kate English and Mr. Adam Putnam. Ms. English will serve on the Compensation Committee and Nominating and Governance Committee. Mr. Putnam will serve on the Audit Committee and the Nominating and Governance Committee. Each will serve until the 2021 annual meeting of the Company’s shareholders or until her or his earlier death, resignation, or removal in accordance with the Amended and Restated Bylaws of the Company. This brings Alico’s total board membership to nine. Mr. Benjamin Fishman, Chairman of Alico’s board of directors, commented “We are pleased to welcome Ms. English and Mr. Putnam to our board...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.